Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Deepa, Bhojwani"'
Autor:
Haley Newman, Suzanne P. MacFarland, Garrett M. Brodeur, Timothy Olson, Deepa Bhojwani, Jamie Stokke, Alexandra E. Kovach, Mary Egan Clark, Minjie Luo, Marilyn Li, Amish Shah, Stephen P. Hunger
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Externí odkaz:
https://doaj.org/article/e5934ce82a1d4d1ea40be677dec2b6f5
Autor:
Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, Alan S Wayne, Deepa Bhojwani, Ashish Bajel, Bhagirathbhai Dholaria, Rawan Faramand, Ryan Mattison, Michael Rettig, Ouiam Bakkacha, John Muth, Angela Pannunzio, Brett Ramsey, Eileen Mcnulty, Matthew Cooper, Jan Davidson-Moncada, Kenneth Jacobs, John Dipersio
Publikováno v:
HemaSphere, Vol 7, p e1789302 (2023)
Externí odkaz:
https://doaj.org/article/54e632fd8a1741b4b44130773003313c
Autor:
Heather A. Ogana, Samantha Hurwitz, Chih-Lin Hsieh, Huimin Geng, Markus Müschen, Deepa Bhojwani, Mark A. Wolf, James Larocque, Michael R. Lieber, Yong Mi Kim
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DN
Externí odkaz:
https://doaj.org/article/16124452d48a4bd1a4732545972846eb
Autor:
Sharon Wu, Mengxi Wang, Amani Alqahtani, Mimi Lou, Wendy Stock, Deepa Bhojwani, Houda Alachkar
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 150, Iss , Pp 113000- (2022)
Asparaginase is an integral component of acute lymphoblastic leukemia (ALL)33 Acute Lymphoblastic Leukemia ALL treatment. Hepatotoxicity related to asparaginase is one of the most common treatment-related toxicities in ALL therapy. Hispanic children
Externí odkaz:
https://doaj.org/article/6dbd6858f9594d4290ce54cb3e2af072
Autor:
Yongsheng Ruan, Hye Na Kim, Heather A. Ogana, Zesheng Wan, Samantha Hurwitz, Cydney Nichols, Nour Abdel-Azim, Ariana Coba, Seyoung Seo, Yong-Hwee Eddie Loh, Eun Ji Gang, Hisham Abdel-Azim, Chih-Lin Hsieh, Michael R. Lieber, Chintan Parekh, Dhananjaya Pal, Deepa Bhojwani, Donald L. Durden, Yong-Mi Kim
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The PI3K/Akt pathway—and in particular PI3Kδ—is known for its role in drug resistant B-cell acute lymphoblastic leukemia (B-ALL) and it is often upregulated in refractory or relapsed B-ALL. Myc proteins are transcription factors responsible for
Externí odkaz:
https://doaj.org/article/9d2a16f695cc4722b8574521dd391e56
Autor:
Amy K. Keating, Nathan Gossai, Christine L. Phillips, Kelly Maloney, Kristen Campbell, Andrew Doan, Deepa Bhojwani, Michael J. Burke, Michael R. Verneris
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 1926-1929 (2019)
Externí odkaz:
https://doaj.org/article/4412f34b34974ab999946ef0e2cb7a47
Autor:
Thao T. Truong, Alex Ryutov, Utsav Pandey, Rebecca Yee, Lior Goldberg, Deepa Bhojwani, Paibel Aguayo-Hiraldo, Benjamin A. Pinsky, Andrew Pekosz, Lishuang Shen, Scott D. Boyd, Oliver F. Wirz, Katharina Röltgen, Moiz Bootwalla, Dennis T. Maglinte, Dejerianne Ostrow, David Ruble, Jennifer H. Han, Jaclyn A. Biegel, Maggie Li, ChunHong Huang, Malaya K. Sahoo, Pia S. Pannaraj, Maurice O'Gorman, Alexander R. Judkins, Xiaowu Gai, Jennifer Dien Bard
Publikováno v:
EBioMedicine, Vol 67, Iss , Pp 103355- (2021)
Background: There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses
Externí odkaz:
https://doaj.org/article/42209873b5b849b2806a3d10b8822b27
Autor:
G. A. Amos Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Luisi, Véronique Minard-Colin, Birgit Burkhardt, Monelle Tamegnon, Steven Sun, Madeliene Curtis, Sanjay Deshpande, Kerri Nottage, Angela Howes, Srimathi Srinivasan, Deepa Bhojwani, Robin Norris, Mitchell Cairo
Publikováno v:
Blood advances, 7(4), 602-610. American Society of Hematology
Part 1 results of the open-label, randomized, global phase 3 SPARKLE trial supported continued assessment of ibrutinib with either modified rituximab, ifosfamide, carboplatin, and etoposide (RICE) or rituximab, vincristine, ifosfamide, carboplatin, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e398afe86edb89e121a404f65bd64a1
http://www.scopus.com/inward/record.url?scp=85149128353&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85149128353&partnerID=8YFLogxK
Autor:
Emily M. Hsieh, Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M. Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W. Lee, Amanda DiNofia, Stephan A. Grupp, Michael R. Verneris, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca A. Gardner, Lia Gore, Nirali N. Shah, Adam J. Lamble
Publikováno v:
Blood Advances. 6:5222-5226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d68d14ce10585b90054349031f77f4
https://doi.org/10.1182/bloodadvances.2022008093
https://doi.org/10.1182/bloodadvances.2022008093
Autor:
Jeffrey Jean, Alexandra E. Kovach, Andrew Doan, Matthew Oberley, Jianling Ji, Ryan J. Schmidt, Jaclyn A. Biegel, Deepa Bhojwani, Gordana Raca
Publikováno v:
Blood Advances. 6:3343-3346
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f440c026e9ec94caeefa7510f9fa96e7
https://doi.org/10.1182/bloodadvances.2021006328
https://doi.org/10.1182/bloodadvances.2021006328